25 May, 2022
The Penta ID Network Meeting 2022 (PIM, 28-30 April 2022) gave our members – the Penta family – a great opportunity to meet face-to-face, after more than two years of distance due to the COVID-19 pandemic.
The beautiful Sorrento in Italy set the stage for three days of talks, discussions, debates, and social activities (including a visit to nearby Pompei and a historical restaurant in the city).
Over the years, PIM has strengthened the connections between collaborating institutions, industries, and international organizations associated with the Penta ID Network. These connections have helped propel our research portfolio and fuelled innovation in our key scientific areas.
Discussions during PIM 2022 focused on the Penta ID Network’s activities in the areas of HIV, Hepatitis B and C, COVID-19, ZIKV/arboviruses, fungal infections, infections in pregnancy and other recently developed Penta projects and plans. Recent data about new antivirals, antimicrobials, and vaccines were also presented and so were some sessions dedicated to antimicrobial resistance and the future of real-world data in research.
Children are at the centre of everything we do. So at PIM 2022, two members of our Youth Trials Board, a group of young people who participate in our paediatric clinical trials as partners and advisors, were involved in the debates around the importance of research and gave the Network a unique perspective on what clinical research means to them. Additionally, the Early Career Researchers of the Penta ID Network presented their plans for fostering the work of young scientists with the support of Penta.
We are sure that the PIM 2022 will result in many new partnerships, collaborations, projects, and opportunities for future work in Penta!